Fingolimod alleviates the decrease in inflammation and reduces proinflammatory cytokines through the Akt/mTOR/NF‐kB axis in c‐EAN rats, which could be beneficial for the development of CIDP‐related research. The gene discussed is NFKB1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.